Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $52.70 | Total: $263.50 |
| 1 | 10 | $44.64 | Total: $446.40 |
| 1 | 25 | $37.82 | Total: $945.50 |
| 1 | 50 | $32.24 | Total: $1,612.00 |
| 1 | 100 | $27.90 | Total: $2,790.00 |
Overview
Latanoprostene bunod (LBN) is nitric oxide (NO)-donating prostaglandin F2a analog and is a topical ophthalmic therapeutic. It is used for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (OHT).
Chemical Properties
| Molecular Formula | C27H41NO8 |
| Molecular Weight | 507.62 |
| CAS Numbers | 860005-21-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(=O)OCCCCO[N+]([O-])=O)CCc1ccccc1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Cavet ME, et al. The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod Review of Nonclinical Studies. J Ocul Pharmacol Ther. 2018 JanFeb;34[1-2] 52-60.